Literature DB >> 16284768

Serum lipid profile in patients with systemic sclerosis: relationship to the thyreometabolic state.

P J Kotyla, J Gozdzik, M Lewicki, A T Kotulska, E J Kucharz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16284768     DOI： 10.1007/s00296-005-0075-2

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN： 0172-8172            Impact factor:   2.631


× No keyword cloud information.
  8 in total

1.  Macrovascular disease and systemic sclerosis.

Authors:  M Ho; D Veale; C Eastmond; G Nuki; J Belch
Journal:  Ann Rheum Dis       Date:  2000-01       Impact factor: 19.103

2.  Increased susceptibility to oxidation of low-density lipoproteins isolated from patients with systemic sclerosis.

Authors:  K R Bruckdorfer; J B Hillary; T Bunce; R Vancheeswaran; C M Black
Journal:  Arthritis Rheum       Date:  1995-08

3.  Anti-lipoprotein lipase antibody in systemic sclerosis: association with elevated serum triglyceride concentrations.

Authors:  Masanari Kodera; Ikuko Hayakawa; Kazuhiro Komura; Koichi Yanaba; Minoru Hasegawa; Kazuhiko Takehara; Shinichi Sato
Journal:  J Rheumatol       Date:  2005-04       Impact factor: 4.666

4.  Lipoprotein profile in limited systemic sclerosis.

Authors:  Eduardo F Borba; Claudia T L Borges; Eloísa Bonfá
Journal:  Rheumatol Int       Date:  2005-02-08       Impact factor: 2.631

5.  Thyroid disease in progressive systemic sclerosis: increased frequency of glandular fibrosis and hypothyroidism.

Authors:  M B Gordon; I Klein; A Dekker; G P Rodnan; T A Medsger
Journal:  Ann Intern Med       Date:  1981-10       Impact factor: 25.391

6.  Prospective evaluation of thyroid function in patients with systemic sclerosis (scleroderma).

Authors:  L E Kahl; T A Medsger; I Klein
Journal:  J Rheumatol       Date:  1986-02       Impact factor: 4.666

7.  Limited scleroderma is associated with increased prevalence of macrovascular disease.

Authors:  P Youssef; T Brama; H Englert; J Bertouch
Journal:  J Rheumatol       Date:  1995-03       Impact factor: 4.666

8.  Increased prevalence of symptomatic macrovascular disease in systemic sclerosis.

Authors:  D J Veale; T A Collidge; J J Belch
Journal:  Ann Rheum Dis       Date:  1995-10       Impact factor: 19.103
  8 in total
  1 in total

Review 1.  Lipid Alterations in Systemic Sclerosis.

Authors:  Zuzanna Gogulska; Zaneta Smolenska; Jacek Turyn; Adriana Mika; Zbigniew Zdrojewski
Journal:  Front Mol Biosci       Date:  2021-12-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.